August 2007
Mayo Clinic Proceedings;Aug2007, Vol. 82 Issue 8, p1017
Academic Journal
Correction notice
Several corrections to the articles are presented including "Flouride-Related Bone Disease Associated With Habitual Tea Consumption" that was published in the June 2007 issue, "Oral Cancer" that was published in the July 2007 issue and "Role of Lipoprotein-Associated Phospholipase A in Predicting Risk of Cardiovascular Disease" that published in the July 2007 issue.


Related Articles

  • MRI and CT findings of infected cephalhaematoma complicated by skull vault osteomyelitis, transverse venous sinus thrombosis and cerebellar haemorrhage. Chan, Monica S.; Wong, Yiu-chung; Lau, Shirley P.; Lau, Kit-yu; Ou, Yvonne // Pediatric Radiology;May2002, Vol. 32 Issue 5, p376 

    We present the CT and MRI findings of an 8-day-old infant with an infected cephalhaematoma complicated by skull osteomyelitis, venous sinus thrombosis and left cerebellar haemorrhage.

  • Plenary lecture abstracts.  // Osteoporosis International;Apr2006 Supplement 14, Vol. 17, p125 

    The article presents abstracts of research about osteoporosis. They include "Determinants of Fracture: Load Versus Strength," "Cardiovascular Diseases and Osteoporosis: From Epidemiology to Biology," "Rationale for Choosing Anabolic or Antiresorptive Treatment" and "Androgen and Estrogen in Bone."

  • Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Semba, R. D.; Houston, D. K.; Bandinelli, S.; Sun, K.; Cherubini, A.; Cappola, A. R.; Guralnik, J. M.; Ferrucci, L. // European Journal of Clinical Nutrition;Feb2010, Vol. 64 Issue 2, p203 

    Background/Objectives:Vitamin D deficiency is associated with cardiovascular disease, osteoporosis, poor muscle strength, falls, fractures and mortality. Although older adults are at a higher risk of vitamin D deficiency, the relationship of serum 25-hydroxyvitamin D (25(OH)D) with all-cause and...

  • Cardiovascular risk and the menopause. Currie, Heather // GP: General Practitioner;4/17/2009, p30 

    The article reports on the long-term effects of menopause among women's health. It discusses the risk factors for cardiovascular diseases. It suggests that general practitioners discussing about menopausal symptoms among women should not only tackle those symptoms but also think long term and...

  • Have a Health New Year! Bender, Michele // Working Mother;Dec2005, Vol. 28 Issue 10, p30 

    Presents a question and answer advisory on various issues concerning health. Ways to reduce the risk of heart disease; Suggestion that family history of osteoporosis increases chances of getting this bone-thining disease; Importance of sleep for good health.

  • Innovating in New Market Spaces. Finn, Susan Calvert // Journal of Women's Health & Gender-Based Medicine;Sep99, Vol. 8 Issue 7, p885 

    The article explores trends in the field of women's health. Today, 35 million Americans are 65 years old or older, and that number will double in just over 30 years. In fact, most of the developed world is aging as people live longer and birth rates decline. Age and health status change, but...

  • Pro: Cardiovascular calcifications are clinically relevant. Bover, Jordi; Evenepoel, Pieter; Ureña-Torres, Pablo; Vervloet, Marc G.; Brandenburg, Vincent; Mazzaferro, Sandro; Covic, Adrian; Goldsmith, David; Massy, Ziad A.; Cozzolino, Mario // Nephrology Dialysis Transplantation;Mar2015, Vol. 30 Issue 3, p345 

    It is increasingly acknowledged that mineral and bone disorders (MBDs) contribute to the excessively high cardiovascular (CV) disease morbidity and mortality observed in patients with chronic kidney disease (CKD). There is ongoing debate as to whether screening for CV calcification, one of the...

  • Genome-Wide Association Study of Lp-PLA2 Activity and Mass in the Framingham Heart Study. Suchindran, Sunil; Rivedal, David; Guyton, John R.; Milledge, Tom; Xiaoyi Gao; Benjamin, Ashlee; Rowell, Jennifer; Ginsburg, Geoffrey S.; McCarthy, Jeanette J. // PLoS Genetics;Apr2010, Vol. 6 Issue 4, p1 

    Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an emerging risk factor and therapeutic target for cardiovascular disease. The activity and mass of this enzyme are heritable traits, but major genetic determinants have not been explored in a systematic, genome-wide fashion. We carried out a...

  • Lipoprotein-Associated Phospholipase A2 and Risk Stratification for Cardiovascular Disease: Not Ready for "Prime Time". Steinberg, Daniel I.; Alexander Mayer // Mayo Clinic Proceedings;Feb2007, Vol. 82 Issue 2, p155 

    The article offers information on cardiovascular disease (CVD) and lipoprotein-associated phospholipase A2 (Lp-PLA2) in the U.S. Cardiovascular disease was the contributing cause of death in 58% of all American deaths in 2003. Research has focused on whether markers of inflammation can aid the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics